Latest News of MYC
What is rapamycin? Devotees claim the drug can slow down aging
By New York Post |
3 days ago
Rapamycin, a compound used in organ transplant patients, is gaining attention as an anti-aging drug. By inhibiting mTOR, it may reduce inflammation, promote autophagy, and potentially combat diseases ...
Forbes EQ BrandVoice: DEI Consultant Dr. Jamyce Curtis Banks Does Whatever It Takes...And It's Never One-Size-Fits-All
By Forbes |
3 weeks ago
Dr. Jamyce Curtis Banks transitioned from educator to DEI consultant, focusing on equity and inclusion in organizations. Through her consulting practice, she offers customized solutions to improve cul...
Formycon First Half 2024 Earnings: €0.58 loss per share (vs €0.11 profit in 1H 2023)
By Yahoo! Finance |
1 month ago
The chart displays figures for the trailing 12 months. Forecast predicts Formycon's revenue will increase by 33% annually for the next 3 years, outperforming the Biotechs industry in Europe at 20%. Th...
-
Commonly used drug may extend women's fertility, claim researchers - here's what you need to know about rapamycin
By CNN | 1 month agoStudies suggest rapamycin may extend a woman's fertility by delaying ovarian aging. Research in mice shows promise, with potential benefits for human fertility. Clinical trials are ongoing to confirm ...
-
Novo Nordisk confident of amycretin obesity drug launch this decade
By Reuters | 6 months agoBy Maggie Fick and Jacob Gronholt-PedersenBAGSVAERD, Denmark (Reuters) - Novo Nordisk is very comfortable it will be able to launch the pill version of its experimental weight loss drug amycretin ...